Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice.
Jønch A.E., Douard E., Moreau C., Van Dijck A., Passeggeri M., Kooy F., Puechberty J., Campbell C., Sanlaville D., Lefroy H. et al., 2019/10. Journal of medical genetics, 56 (10) pp. 701-710. Peer-reviewed.
ici le détail
